May 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
According to forecasts, the global musculoskeletal disorders treatment market will grow from USD 197.18 billion in 2024 to USD 353.12 billion by 2034, with an expected CAGR of 6%. Musculoskeletal disorder treatment includes pain relief, physical therapy, medications, and lifestyle changes to improve movement and function. In severe cases, surgery m...
April 21, 2026
Based on market forecasts, the inflammatory bowel disease treatment sector will expand from USD 21.01 billion in 2024 to USD 35.88 billion by 2034, experiencing a CAGR of 5.5%. The Inflammatory Bowel Disease (IBD) treatment market focuses on medications, biologics, and therapies for conditions like Crohn’s disease and ulcerative colitis. Grow...
April 21, 2026
According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous efforts taken by governments and key stakeholders drive the market's growth....
April 21, 2026
Market insights predict the global non-small lung carcinoma industry will increase from USD 9.1 billion in 2024 to USD 23.67 billion by 2034, achieving a CAGR of 10.03%. Clinical research, development of new treatment options, and prevalence of NSCLC is driving the growth of the market....
April 21, 2026
According to market projections, the global chronic lower back pain market, valued at USD 2.69 billion in 2024, is anticipated to reach USD 6.69 billion by 2034, growing at a CAGR of 9.52% over the next decade. The increasing geriatric population with arthritis is one of the leading causes of chronic lower back pain, which is driving the market&rsq...
April 21, 2026
Based on market forecasts, the catheter related bloodstream infection sector will expand from USD 1.61 billion in 2024 to USD 2.65 billion by 2034, experiencing a CAGR of 5.13%. The increasing geriatric population and chronic conditions are driving the growth of the market....
April 21, 2026
Projections indicate that, U.S. cell therapy industry is projected to rise from USD 6.62 billion in 2024 to USD 46.26 billion by 2034, reflecting a CAGR of 21.46% over the next decade. The increasing prevalence of chronic conditions is driving the growth of the market....
April 21, 2026
According to market projections, the global retinal biologics market, valued at USD 29.14 billion in 2026, is anticipated to reach USD 57.86 billion by 2035, growing at a CAGR of 7.92% over the next decade. The growing geriatric population drives the market’s growth....
April 21, 2026
According to forecasts, the global biomaterials market will grow from USD 206.01 billion in 2024 to USD 880.21 billion by 2034, with an expected CAGR of 15.63%. It is anticipated that the increasing prevalence of musculoskeletal and chronic skeletal disorders would increase demand for biomaterial-based implants....
April 21, 2026
According to market projections, the vitrification sector is expected to grow from USD 9.62 billion in 2024 to USD 45.39 billion by 2034, reflecting a CAGR of 16.78%. The global market is expected to rise because of factors including rising knowledge about reproductive health, growing demand for assisted reproductive technologies (ARTs), and an inc...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
